about
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...
Read More
3.04
0.17
(5.92%)
727.0K
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Entera Bio Ltd is on 12 Aug 2026 for the purpose of Canaccord Genuity 46th Annual Growth Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Entera Bio Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..